AGEN — Agenus Inc.

Agenus Inc. , a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies.

Sector

Healthcare

Industry

Biotechnology

Market Cap

$183.9M

P/E Ratio

1471.17

Beta

1.61

52-Week Range

1.96-7.34

Dividend Yield

$0.00

CEO

Garo H. Armen

Employees

316

IPO Date

Feb 8, 2000

Exchange

NASDAQ